Response to erythropoiesis‐stimulating agents in patients with WHO‐defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T). (3rd March 2020) - Antelo, Guadalupe; Mangaonkar, Abhishek A.; Coltro, Giacomo; Buradkar, Ajinkya; Lasho, Terra L.; Finke, Christy; Carr, Ryan; Binder, Moritz; Gangat, Naseema; Al‐Kali, Aref; Elliott, Michelle A.; King, Rebecca L.; et al.